We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+8.31%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$5.17B
AUM Growth
+$808M
Cap. Flow
+$417M
Cap. Flow %
8.07%
Top 10 Hldgs %
16.85%
Holding
722
New
51
Increased
415
Reduced
155
Closed
32

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$43.8M
2
GILD icon
Gilead Sciences
GILD
+$40.8M
3
GE icon
GE Aerospace
GE
+$37.3M
4
MSI icon
Motorola Solutions
MSI
+$24.6M
5
REGN icon
Regeneron Pharmaceuticals
REGN
+$23.3M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$53.2M
2
AMGN icon
Amgen
AMGN
+$30.4M
3
MJN
Mead Johnson Nutrition Company
MJN
+$21.5M
4
CNI icon
Canadian National Railway
CNI
+$20.9M
5
BDX icon
Becton Dickinson
BDX
+$18M

Sector Composition

Rank Sector Weight
1 Healthcare 24.05%
2 Financials 13.76%
3 Technology 12.91%
4 Communication Services 9.31%
5 Industrials 8.11%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GMED icon
476
Globus Medical
GMED
$10.4B
$1.48M 0.03%
50,000
– –
COL
477
DELISTED
Rockwell Collins
COL
$1.48M 0.03%
15,225
+103
+0.7% +$9.68K
CHRW icon
478
C.H. Robinson
CHRW
$22B
$1.46M 0.03%
18,925
+1,243
+7% +$95.5K
RSG icon
479
Republic Services
RSG
$66.7B
$1.46M 0.03%
23,195
-8,387
-27% -$502K
AZO icon
480
AutoZone
AZO
$48.3B
$1.45M 0.03%
2,006
+312
+18% +$231K
ONCE
481
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$1.44M 0.03%
27,000
-9,000
-25% -$534K
LXFT
482
DELISTED
Luxoft Holding, Inc.
LXFT
$1.44M 0.03%
23,000
-12,400
-35% -$730K
LRCX icon
483
Lam Research
LRCX
$382B
$1.43M 0.03%
111,720
+28,970
+35% +$341K
APH icon
484
Amphenol
APH
$188B
$1.43M 0.03%
80,368
+5,068
+7% +$87.7K
L icon
485
Loews
L
$24.3B
$1.42M 0.03%
30,401
+671
+2% +$31.4K
MYGN icon
486
Myriad Genetics
MYGN
$530M
$1.42M 0.03%
74,000
– –
RL icon
487
Ralph Lauren
RL
$22.2B
$1.41M 0.03%
17,250
-7,857
-31% -$648K
SGMO
488
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$1.4M 0.03%
270,000
+70,000
+35% +$281K
CLX icon
489
Clorox
CLX
$11.6B
$1.4M 0.03%
10,391
+1,815
+21% +$235K
DOC icon
490
Healthpeak Properties
DOC
$15.4B
$1.39M 0.03%
44,555
+4,852
+12% +$149K
NWL icon
491
Newell Brands
NWL
$2.16B
$1.39M 0.03%
29,400
+5,876
+25% +$279K
CCL icon
492
Carnival Corporation Ltd
CCL
$36.1B
$1.38M 0.03%
23,449
+4,839
+26% +$271K
CXO
493
DELISTED
CONCHO RESOURCES INC.
CXO
$1.38M 0.03%
10,744
+3,939
+58% +$530K
ES icon
494
Eversource Energy
ES
$28.2B
$1.37M 0.03%
23,319
+5,744
+33% +$327K
AERI
495
DELISTED
Aerie Pharmaceuticals
AERI
$1.36M 0.03%
30,000
-4,000
-12% -$178K
WU icon
496
Western Union
WU
$2.57B
$1.36M 0.03%
66,740
-5,718
-8% -$117K
HST icon
497
Host Hotels & Resorts
HST
$16.8B
$1.35M 0.03%
72,164
-34,634
-32% -$633K
BBY icon
498
Best Buy
BBY
$18B
$1.34M 0.03%
27,343
+4,558
+20% +$204K
VTR icon
499
Ventas
VTR
$48.9B
$1.34M 0.03%
20,538
+3,438
+20% +$214K
DISH
500
DELISTED
DISH Network Corp.
DISH
$1.33M 0.03%
21,000
+3,604
+21% +$223K
18 19
20
21 22

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2017 Portfolio in Review

As of Q1 2017, Candriam SCA held 722 positions worth $5.17B, up 19% from $4.36B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Candriam SCA deployed $417M of net new capital in Q1 2017, opening 51 new positions and adding to 415 existing holdings. Its largest new stake was Copart: 1,499,296 shares worth $11.6M.

By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 24% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Johnson & Johnson, an estimated $53.2M trimmed.

  • Candriam SCA's largest Q1 2017 buy was Copart: 1,499,296 shares worth $11.6M.
  • Candriam SCA added most to Celgene Corp in Q1 2017, an estimated $43.8M increase.
  • Candriam SCA's biggest Q1 2017 reduction was Johnson & Johnson, cutting an estimated $53.2M.
  • Candriam SCA fully exited TechnipFMC in Q1 2017, selling an estimated $7.64M.
  • Candriam SCA's ten largest holdings make up 17% of its $5.17B portfolio in Q1 2017.
  • Candriam SCA opened 51 new positions and closed 32 in Q1 2017.
  • Candriam SCA's portfolio value rose 19% quarter-over-quarter to $5.17B.

Based on Candriam SCA's 13F filing for Q1 2017, filed 21 Apr 2017.